Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-01

Clinical Trial Update: Salvage Ovarian FANG™ Vaccine + Carboplatinum [Phase 2]

View source ↗

Summary

Phase 2 trial results for Gradalis' Salvage Ovarian FANG vaccine in combination with carboplatin have been completed, with results posted for stage III and stag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARBOPLATIN (Carboplatin)
  • FANG™ Vaccine

Snippet

Sponsor: Gradalis, Inc. | Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-01